ERIC A. ROSE, M.D. - Corporate Board Profile

Filing Date	Source Excerpt
2005-05-13	Dr. Rose received a B.A., summa cum laude, in Psychology from Columbia University and an M.D. from Columbia University College of Physicians and Surgeons.
2006-05-01	Dr. Rose received a B.A., summa cum laude, in Psychology from Columbia University and an M.D. from Columbia University College of Physicians and Surgeons.
2007-04-30	Dr. Rose received a B.A., summa cum laude, in Psychology from Columbia University and an M.D. from Columbia University College of Physicians and Surgeons. He is Chairman & CEO of SIGA Technologies, a biotechnology company.
2008-04-29	Dr. Rose received a B.A., summa cum laude, in Psychology from Columbia University and an M.D. from Columbia University College of Physicians and Surgeons.

SIGA TECHNOLOGIES INC

Filing Date	Source Excerpt
2001-07-31	Eric A. Rose, M.D. has served as a Director of Siga since April 19, 2001. From April 19, 2001 until June 21, 2001, Dr. Rose served as Interim Chief Executive Officer of Siga. Dr. Rose is currently Chairman of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital, a position he has held since August 1994. Dr. Rose is a past President of the International Society for Heart and Lung Transplantation. Dr. Rose was recently appointed as Morris & Rose Milstein Professor of Surgery at Columbia University's College of Physicians and Surgeons' Department of Surgery. Dr. Rose is also a Director of the following corporation that files reports pursuant to the Securities Exchange Act of 1934: Nexell Therapeutics Inc. (f/k/a VimRx). Dr. Rose is a graduate of both Columbia College and Columbia University College of Physicians & Surgeons. During fiscal year 2000, no fees were paid to directors, and no directors were reimbursed for expenses incurred. Subject to the approval of the amendment and restatement of Siga's Amended 1996 Incentive and Non-Qualified Stock Option Plan (the "Option Plan") by our stockholders (Proposal 3 to be voted upon at the meeting to which this Proxy Statement relates), Siga has granted options ("Contingent Options") to purchase shares of Siga common stock to its directors under that plan. The number of shares for which each director has been granted Contingent Options is set forth in parentheses after his name: Eric A. Rose (600,000). The exercise price for each Contingent Option will be $2.50, the fair market value at the date of grant, and all Contingent Options will be immediately exercisable upon approval of the amendment and restatement of the Option Plan.
2002-11-07	Eric A. Rose, M.D. has served as a Director of SIGA since April 19, 2001. From April 19, 2001 until June 21, 2001, Dr. Rose served as Interim Chief Executive Officer of SIGA. Dr. Rose is currently Chairman of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital, a position he has held since August 1994.
2003-12-05	Eric A. Rose, M.D. 51 Director Eric A. Rose, M.D. has served as a director of SIGA since April 19, 2001.
2004-11-22	Eric A. Rose, M.D. * 53 Director Eric A. Rose, M.D. has served as a director of SIGA since April 19, 2001. From April 19, 2001 until June 21, 2001, Dr. Rose served as Interim Chief Executive Officer of SIGA.
2005-04-29	Eric A. Rose, M.D. has served as a director of SIGA since April 19, 2001. From April 19, 2001 until June 21, 2001, Dr. Rose served as Interim Chief Executive Officer of SIGA. Dr. Rose is currently Chairman of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital, a position he has held since August 1994. Dr. Rose is a past President of the International Society for Heart and Lung Transplantation. Dr. Rose was recently appointed as Morris & Rose Milstein Professor of Surgery at Columbia University's College of Physicians and Surgeons' Department of Surgery. Dr. Rose is a director of PharmaCore, Inc., TransTech Pharma, Inc. and a former director of Nexell Therapeutics Inc. (f/k/a VimRx). Dr. Rose is a graduate of both Columbia College and Columbia University College of Physicians & Surgeons.
2006-11-20	Eric A. Rose, M.D. has served as a director of SIGA since April 19, 2001. ... Directors who are not currently receiving compensation as officers or employees of the Company or any of its affiliates receive $1,000 per meeting for board meetings ...
2007-04-27	Eric A. Rose, M.D. was elected Chairman of the Board of SIGA at a Board meeting on January 25, 2007. On March 1, 2007, Dr. Rose became the Company's Chief Executive Officer after taking a leave from his position as Chairman of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital, a position he has held since August 1994.
2007-06-15	Eric A. Rose, M.D. Chief Executive Officer and Chairman of the Board
2008-04-09	Eric A. Rose, M.D. was elected Chairman of the Board of SIGA in January 25, 2007. On March 1, 2007, Dr. Rose became the Company’s Chief Executive Officer...Dr. Rose is a past President of the International Society for Heart and Lung Transplantation...The Board of Directors recommends that the stockholders vote for the election of Dr. Rose as director.
2009-04-08	Eric A. Rose, M.D. was elected Chairman of the Board of Directors on January 25, 2007 and on March 1, 2007, became the Companys Chief Executive Officer. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001.
2010-04-12	Eric A. Rose, M.D. was elected Chairman of the Board of Directors on January 25, 2007, and, on March 1, 2007, became the Company’s Chief Executive Officer. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001.
2011-04-12	Eric A. Rose, M.D. was elected Chairman of the Board of Directors on January 25, 2007, and, on March 1, 2007, became the Company’s Chief Executive Officer. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001.
2012-04-27	Eric A. Rose, M.D. was elected Chairman of the Board of Directors on January 25, 2007, and, on March 1, 2007, became the Companys Chief Executive Officer. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001.
2013-04-16	Eric A. Rose, M.D. was elected Chairman of the Board of Directors on January 25, 2007, and, on March 1, 2007, became the Companys Chief Executive Officer. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001.
2014-04-15	Eric A. Rose, M.D. was elected Chairman of the Board of Directors on January 25, 2007, and, on March 1, 2007, became the Companys Chief Executive Officer. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001.
2015-04-14	Eric A. Rose, M.D. was elected Chairman of the Board of Directors on January 25, 2007, and, on March 1, 2007, became the Companys Chief Executive Officer. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001.
2016-04-18	Eric A. Rose, M.D. was elected Chairman of the Board of Directors on January 25, 2007, and, on March 1, 2007, became the Company’s Chief Executive Officer. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001.
2017-04-17	Eric A. Rose, M.D. was appointed Executive Chairman of the Board of Directors on October 13, 2016. Prior to such date, he had served as Chairman of the Board of Directors since January 25, 2007, and as the Company’s Chief Executive Officer since March 1, 2007. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001.
2018-04-18	Eric A. Rose, M.D. was appointed Executive Chairman of the Board of Directors on October 13, 2016. Prior to such date, he had served as Chairman of the Board of Directors since January 25, 2007, and as the Companys Chief Executive Officer since March 1, 2007. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001.
2019-04-29	Eric A. Rose, M.D. was appointed Chairman of the Board of Directors on October 13, 2018. ... Dr. Rose continues to serve as Chairman of the Board. ... Director Compensation ... Eric A. Rose, M.D.⁽⁵⁾ ... Executive Chairman of the Board of Directors until October 13, 2018; Chairman thereafter. Refer to Summary Compensation Table for applicable details. ... Fees Earned ($): 8,425 ... All Other Compensation ($): 42,935 ... Total ($): 51,360.
2020-04-28	Eric A. Rose, M.D. was appointed Chairman of the Board of Directors on October 13, 2018. ... The Board of Directors recommends that the stockholders vote “FOR” the election to the Board of each of the following nominees ... Eric A. Rose, M.D., Age 69, Director Since 2001, Chairman of the Board ... Director Compensation ... Eric A. Rose, M.D. ... Total ($) 319,500 ... Represents fees earned for consulting services provided in 2019.

NEPHROS INC

SIGA TECHNOLOGIES INC